Embracing Rival Programs, Juno Ventures Forth With Talk Of Cancer Cure

The richly funded start-up is an unlikely collaboration between rival oncology research centers, both with immunotherapy programs that require complicated cell therapy processes. Coming together under one roof doesn’t mean the competition has ended.